MedTrace Logo

Effects of Compression Mobilization in OA Patients

NCT04944056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2021-09-05

No results posted yet for this study

Summary

The study Design was randomized control trial in which data was collected From Riphah Rehabilitation And Research Center and Pakistan Railway Hospital-IIMCT. Convenient sampling technique was used for data collection. 39 patients having knee osteoarthritis were recruited in this study. After taking consent from patients, patients were divided randomly into two groups through lottery method. The Experimental Group received compression mobilization with Conventional Physiotherapy (n = 19) and the Control group received Conventional Physiotherapy (n = 20). Research data was collected through structural questionnaire. the main variables were ROM, MMT, Muscle length and mBBS.

Conditions

  • Osteo Arthritis Knee

Interventions

OTHER

conventional physiotherapy

* Ultrasound therapy 3-4 minutes. * Tibiofemoral AP and PA glides 1 set x10reps x 3 sets. * Patellar glides 1 set x 5 reps x 3 sets. * Quads isometrics 1 set x 10 reps. * Hams self stretching 1 sets x 10 reps. Home plan: * Quads isometrics 1 set x 10 reps. * Hams self stretching 1 sets x 10 reps. * Active range of motion.

OTHER

compression mobilization

* Ultrasound therapy 3-4 minutes. * Tibiofemoral AP and PA glides 1 set x10reps x 3 sets. * Patellar glides 1 set x 5 reps x 3 sets. * Quads isometrics 1 set x 10 reps. * Hams self stretching 1 sets x 10 reps. * Compression mobilization 1 set x 10 reps x 3sets. Home plan: * Quads isometrics 1 set x 10 reps. * Hams self stretching 1 sets x 10 reps. * Active range of motion.

Sponsors & Collaborators

  • Mir Arif Hussain

    lead INDUSTRY

Principal Investigators

  • Shakeeba Shahzadi, MS-OMPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2021-07-11
Completion
2021-07-11

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04944056 on ClinicalTrials.gov